Forward Pharma A/S reported unaudited consolidated earnings results for the fourth quarter and year ended December 31, 2016. For the quarter, the company reported net loss before taxes of $11,355,000 against $9,917,000 a year ago. Net income was $9,644,000 or $0.20 per share basic and diluted against net loss of $9,581,000 or $0.20 per share basic and diluted a year ago. Non-GAAP net loss was $11,836,000 or $0.25 per share basic and diluted against $8,403,000 or $0.18 per share basic and diluted a year ago. For the year, the company reported net loss before taxes of $54,539,000 against $37,340,000 a year ago. Net loss was $33,336,000 or $0.71 per share basic and diluted against $37,004,000 or $0.79 per share basic and diluted a year ago. Non-GAAP net loss was $40,928,000 or $0.87 per share basic and diluted against $35,396,000 or $0.76 per share basic and diluted a year ago.